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a b s t r a c t
The ischemic stroke cascade is composed of several pathophysiological events, providing multiple targets
for pharmacological intervention. JM-20 (3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro-
1H-pyrido[2,3-b][1,5]benzodiazepine) is a novel hybrid molecule, in which a benzodiazepine portion is
covalently linked to a dihydropyridine ring, forming a new chemical entity with potential multisite
neuroprotective activity. In the present study, JM-20 prevented PC-12 cell death induced either by
glutamate, hydrogen peroxide or KCN-mediated chemical hypoxia. This molecule also protected
cerebellar granule neurons from glutamate or glutamate plus pentylenetetrazole-induced damage at
very low micromolar concentrations. In rat liver mitochondria, JM-20, at low micromolar concentrations,
prevented the Ca2þ-induced mitochondrial permeability transition, as assessed by mitochondrial
swelling, membrane potential dissipation and organelle release of the pro-apoptotic protein cytochrome
c. JM-20 also inhibited the mitochondrial hydrolytic activity of F1F0-ATP synthase and Ca2þ inﬂux.
Therefore, JM-20 may be a multi-target neuroprotective agent, promoting reductions in neuronal
excitotoxic injury and the protection of the mitochondria from Ca2þ-induced impairment as well as
the preservation of cellular energy balance.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Ischemic stroke is a major cause of death and the leading
source of adult-onset disability in many countries (Mukherjee and
Patil, 2011). The recombinant tissue plasminogen activator is
currently the only approved drug for use in humans during the
acute phase of ischemic stroke, and alternative treatments remain
limited (Howells and Donnan, 2010). Despite encouraging pre-
clinical results, none of the evaluated candidates have resulted
in consistent clinical improvements. This may be due to the
multiplicity of mechanisms involved in the neuronal damage
cascade following brain ischemia, which contrasts with the more
simplistic vision of the proposed neuroprotectants (Minnerup and
Schäbitz, 2009). Accumulating pre-clinical evidence indicates that
a highly selective ligand for a given target does not always result in
a clinically efﬁcacious drug, particularly in pathologies that involve
multiple factors, such as cerebral stroke. Therefore, drugs acting at
a single site in the ischemic cascade, such as Ca2þ channel
blockers, glutamate antagonists, GABA agonists, antioxidants/free
radical scavengers, phospholipid precursors, nitric oxide signal-
transduction down-regulators, and anti-inﬂammatory agents,
have generally failed in the bench to bedside translation process
(Ginsberg, 2008).
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Emerging neuroprotective approaches have begun to consider
mitochondrial bioenergetic dysfunction. Evidence suggests that the
mitochondria play a pivotal role in ischemic neuronal injury either by
integrating noxious signals involved in their structural and functional
damage or by pathway ampliﬁcation, which eventually leads to cell
death (Christophe and Nicolas, 2006; Mazzeo et al., 2009; Perez-
Pinzon et al., 2012). Therefore, there has been increasing interest in
the identiﬁcation of new classes of compounds that simultaneously
target several toxic processes in ischemic neuronal cells, including
those that act at the mitochondrial level.
Recently, we obtained a new family of 1,5-benzodiazepines that
structurally differ from the currently available 1,5-benzodiaze-
pines due to the presence of a 1,4 dihydropyridine moiety fused
to the benzodiazepine ring. JM-20 (3-ethoxycarbonyl-2-methyl-4-
(2-nitrophenyl)-4,11-dihydro-1H-pyrido[2,3-b][1,5]benzodiaze-
pine) is a member of this family of compounds (Fig. 1) and has an
anxiolytic proﬁle that is similar to that of diazepam (Figueredo
et al., 2014). Its dihydropyridine moiety does not appear to
interfere with the GABAergic activity associated with its benzo-
diazepine portion but may confer Ca2þ channel blocking proper-
ties, indicating that JM-20 may act as a potential neuroprotectant.
Moreover, mitoprotection is another potential mechanism that
may be involved in the neuroprotective effects of JM-20 because
diazepam and nimodipine, both of which exhibit structural fea-
tures that are similar to those of JM-20, have been reported to
protect neuronal cells in brain ischemia models via mitochondrial
mechanisms (Taya et al., 2000; Sarnowska et al., 2009). In this
context, we hypothesized that JM-20 may protect neural cells from
different toxic mediators that play major roles in the ischemic
cascade by acting as a multifunctional drug, including by prevent-
ing mitochondrial impairment. Thus, in the present study, we
evaluated the protective effects of JM-20 against damage induced
by glutamate, hydrogen peroxide or oxygen/glucose deprivation in
PC-12 cells or rat primary cerebellar neurons, which well known
in vitro models to be relevant to cerebral ischemia (Facci and
Skaper, 2012; Im et al., 2010). We also evaluated the protective
effects of JM-20 against Ca2þ-induced mitochondrial impairment
in rat liver mitochondria, a recognized model that has been used
to study the mitochondrial mechanisms associated with neurode-
generation and to screen for neuroprotectors (Zhu et al., 2002;
Zhang et al., 2008; Wang et al., 2009). We observed that JM-20 is
protective against in vitro neural damage induced by mediators of
the ischemic cascade, and our results indicated that mitoprotec-
tion may play a role in the primary mechanism of action of JM-20.
2. Materials and methods
2.1. Compounds and reagents
All of the chemicals used were of the highest grade available
and were purchased from Sigma-Aldrich (St. Louis, MO, USA),
unless otherwise speciﬁed. Stock solutions of JM-20 were prepared
daily in absolute ethanol or dimethyl sulfoxide (DMSO) and added
to the cell culture or mitochondrial reaction media, respectively, at
1/1000 (v/v) dilutions. Control experiments contained absolute
ethanol or DMSO at a 1/1000 dilution. JM-20 was synthesized,
puriﬁed and characterized as previously reported (Figueredo et al.,
2014).
2.2. Experimental animals
For the mitochondrial assays, adult male Wistar rats (CENPA-
LAB, Havana, Cuba) weighing approximately 200 g were housed in
a temperature-controlled room under a 12 h light/dark cycle with
free access to food and water. The animals (n¼15) were quar-
antined for a minimum of 7 days prior to experimentation.
Primary cultures of cerebellar neurons were prepared from
7-day postnatal male Wistar rats (n¼3) obtained from in-house
breeding colonies at the UCTB Control Biológico (Drug Research
and Development Center, CIDEM, Havana, Cuba). Animal housing,
care, and the application of experimental procedures were in
accordance with institutional guidelines and were conducted
according to approved protocols (Animal Care Committee from
CIDEM, Havana, Cuba).
2.3. PC-12 cell culture
Pheochromocytoma (PC-12) cells were kindly supplied by Bea-
triz Caputto, Ph.D., from Cordoba National University, and Sandra
Verstraeten, Ph.D., from Buenos Aires University, Argentina. Cells at
passage seven were routinely maintained in Dulbecco's Modiﬁed
Essential Medium (DMEM) containing L-glutamine (Sigma, St. Louis,
MO) and supplemented with 10% heat-inactivated equine serum
(Gibco, Life Technologies, USA), 5% inactivated fetal bovine serum,
50 U/ml of penicillin and 10 mg/ml of streptomycin (all of which
were obtained from Sigma, St. Louis, MO) in a humidiﬁed atmo-
sphere containing 95% air/5% CO2 at 37 1C. The growth mediumwas
replaced every 3 days. At day seven, the cells were trypsinized
(Sigma, St. Louis, MO) and seeded at a density of 1.5105 cells/ml
in 96 multiwell ﬂat bottom plates (Corning Costar, Sigma) in 200 μl
of culture medium at 37 1C and were ﬂushed with 5% CO2 in air for
24 h (Choi et al., 2011; Figueredo et al., 2011; Yoon et al., 2011).
2.4. Cerebellar cell cultures
Primary cultures of cerebellar cells were obtained by modifying
previously outlined procedures (Whittemore et al., 1995). Brieﬂy,
whole brains from 7-day postnatal Wistar rats were maintained in
calcium and magnesium-free Hank's Balanced Salt Solution (HBSS,
Gibco, Paisley, UK). The cerebellums were isolated and tissue
pieces were trypsinized (1% trypsin/0.1% DNase; Gibco BRL),
incubated for 20 min at 37 1C, and mechanically dissociated in
DNase (0.05%) using ﬂame polished Pasteur pipettes. The suspen-
sions were centrifuged at 1800g for 3 min at 4 1C, and the resultant
pellets were resuspended and passed through 30 μm Nytex ﬁlters
to remove undissociated cells (Console-Bram et al., 1998). The cells
were then reconstituted in growth medium containing 85% DMEM
containing L-glutamine, 10% fetal bovine serum, 50 U/ml of peni-
cillin and 10 mg/ml of streptomycin. The cells were plated on poly-
L-lysine (Sigma) coated 96-multiwell ﬂat bottom plates (Corning
Costar) at a density of 5105 cells/ml in 200 μl of culture medium
at 37 1C and were ﬂushed with 5% CO2 in air for 72 h.
2.5. Induction of glutamatergic damage in cerebellar and P-C12 cells
After the incubation period, the cells were rinsed with buffered
saline solution and exposed to 50 mM glutamate (PC-12 cells),
Fig. 1. Chemical structure of JM-20 (3-ethoxycarbonyl-2-methyl-4-(2-nitrophe-
nyl)-4,11-dihydro-1H-pyrido[2,3-b][1,5]benzodiazepine).
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15 mM glutamate or 15 mM glutamate plus 40 mM pentylenetetra-
zole (cerebellar granules) in the absence (control) or presence of
JM-20 (0.001–10 μM). Diazepam and nifedipine, both at 1 and
10 mM, were used as reference drugs. The incubation medium
contained a standard Tris-buffered salt solution (25 mM) with the
following composition: 120 mM NaCl, 5.4 mM KCI, 0.8 mM MgCl2,
and 1.8 mM CaCI2, pH 7.4 (Pereira and Oliveira, 1997). The cells
were incubated for 24 h in a humidiﬁed atmosphere containing
95% air and 5% CO2.
2.6. Induction of H2O2-mediated oxidative damage in PC-12 cells
PC-12 cells were damaged with 200 mM H2O2 (Siddiqui et al.,
2011) in the absence (control) or presence of JM-20 (0.1–10 mM).
The incubation medium was the same as that used in the
glutamatergic damage experiments. The cells were incubated for
18 h in a humidiﬁed atmosphere containing 95% air and 5% CO2.
2.7. Induction of cyanide-induced chemical hypoxia in PC-12 cells
For the cyanide-induced injury, the cells were exposed to
0.8 mM KCN in DMEM without glucose in the absence (control)
or presence of JM-20 (0.001–10 μM) over the course of 1 h in a
humidiﬁed atmosphere containing 95% air and 5% CO2. Hypoxia
was terminated by aspirating the poisoned medium and washing
the cells with fresh media in all of the experimental groups,
including the control culture. The reperfusion state was simulated
by the addition of DMEM without KCN and with high glucose
content for 24 h (Satpute et al., 2008). JM-20 was added to the
incubation medium either (i) during the chemical hypoxia and
reperfusion periods or (ii) only during reperfusion period.
2.8. PC-12 and cerebellar granule cell viability assays
Cell viability was measured by the levels of blue formazan
products formed from the colorless 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) by mitochondrial
dehydrogenases, which are only active in viable cells. After the
incubation period, the cells were gently washed with sterile
phosphate buffered saline (PBS), pH 7.2 (200 ml/well), and MTT
(freshly prepared at 0.5 mg/ml in serum-free medium) was added
at 200 ml/well and incubated for 3 h at 37 1C. After MTT with-
drawal, 200 ml of DMSO was added to each well to solubilize the
formazan crystals, and the absorbance of each well was measured
at 540 nm using a microplate reader (POLARstar Omega ﬂuores-
cence spectrophotometer, Germany). The results are expressed
as the percentage of absorbance relative to the undamaged
control cells.
2.9. Isolation of rat liver mitochondria and submitochondrial particle
preparation
Rat liver mitochondria (RLM) were isolated using standard
differential centrifugation (Pedersen et al., 1978; Pardo-Andreu
et al., 2011). The rats were euthanized by decapitation. The livers
(10–15 g) were immediately removed; sliced in medium (50 ml)
consisting of 250 mM sucrose, 1 mM ethyleneglycolbis(β-ami-
noethyl)-N,N,N0,N0-tetraacetic acid (EGTA) and 10 mM 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonic acid (HEPES-KOH), pH 7.2;
and homogenized three times for 15 s at 1 min intervals using a
Potter-Elvehjem homogenizer. The homogenates were centrifuged
(580g, 5 min), and the resulting supernatants were further cen-
trifuged (10,300g, 10 min). The pellets were then suspended in
medium (10 ml) consisting of 250 mM sucrose, 0.3 mM EGTA and
10 mM HEPES–KOH, pH 7.2, and centrifuged (3400g, 15 min).
The ﬁnal mitochondrial pellet was suspended in medium (1 ml)
consisting of 250 mM sucrose and 10 mM HEPES–KOH, pH 7.2, and
used within 3 h. To prepare the submitochondrial particles, the
ﬁnal mitochondrial pellet was frozen and stored at 20 1C. After
24 h, the pellet was thawed and the submitochondrial particles
were prepared, as previously described (Uyemura and Curti, 1992),
and isolated by centrifugation at 100,000g for 45 min. Mitochon-
drial protein levels were determined using the biuret reaction.
2.10. Standard mitochondrial incubation procedure
The mitochondria were energized with 5 mM potassium succi-
nate in a standard incubation medium consisting of 125 mM sucrose,
65 mM KCl, 2 mM inorganic phosphate (Pi), 2.5 mM rotenone and
10 mM HEPES–KOH, pH 7.4, at 30 1C. The respiratory control ratio of
the mitochondria was always in the 4.5–6.0 range.
2.11. Continuous-monitoring mitochondrial assays
The mitochondrial membrane potential was estimated spectro-
ﬂuorimetrically using 10 μM Safranine O as a probe (Zanotti and
Azzone, 1980) in a Model F-4500 Hitachi ﬂuorescence spectro-
photometer (Tokyo, Japan) at the 495/586 nm excitation/emission
wavelength pair; these assays were performed in the presence of
0.1 mM EGTA and 2 mM K2HPO4. Ca2þ inﬂux and efﬂux were
monitored spectroﬂuorimetrically using 150 nM Calcium Green 5N
(Molecular Probes, OR, USA) as a probe at the 506/531 nm
excitation/emission wavelength pair (Rajdev and Reynolds, 1993).
Mitochondrial swelling was estimated spectrophotometrically
based on the decrease in the apparent absorbance at 540 nm
using a Model U-2910 Hitachi spectrophotometer (Japan).
2.12. Western blotting for cytochrome c
Cytochrome c release from the mitochondria was assessed
using Western blotting. After incubation, the harvested mitochon-
dria were resuspended in CellLytic™ (Sigma, USA) lysis buffer for
2 min on ice and centrifuged at 10,000g for 5 min at 4 1C. Equal
amounts of mitochondrial proteins (50 mg, quantiﬁed using the
Biuret method) from the resulting supernatants were separated
using SDS–PAGE (12%) and transferred to nitrocellulose mem-
branes. After being blocked with 5% non-fat milk, the membranes
were washed with TBST (TBS: Tris-buffered-saline, 50 mM Tris,
150 mM NaCl, pH 7.5, with 0.1% Tween 20) and incubated with a
puriﬁed mouse anti-cytochrome c antibody from BD Biosciences
Pharmingen (San Diego, CA, USA) at a 1:2000 dilution overnight.
After being washed three times with TBST, a secondary anti-mouse
antibody at a 1:10,000 dilution was applied for 2 h, followed by
horseradish peroxidase-coupled detection. The blots were treated
with ECL reagents for 5 min and exposed to CL-Xposure ﬁlms. The
blots were scanned and densitometric analyses of the scanned
images were performed using Scion Image-Release Beta 4.02
software.
2.13. Determination of the hydrolytic activity of F1F0-ATP synthase
The hydrolytic activity of F1F0-ATP synthase was assessed in
submitochondrial particles by measuring the amount of inorganic
phosphate released by MgATP hydrolysis (Heinonen and Lahti,
1981) at 355 nm. The reaction was initiated by the addition of
MgATP (10 mM) to 1 ml of medium (100 mM sucrose, 80 mM KCl
and 50 mM HEPES–KOH, pH 7.4, at 37 1C) containing submito-
chondrial particles (20 μg of protein) in the absence or presence of
JM-20 (5 mM), oligomycin (1 mM), or Triton X-100 0.1% (v/v) and
was terminated by the addition of 0.5 ml of 30% trichloroacetic
acid. The hydrolytic activity of F1F0-ATP synthase was also assessed
in isolated mitochondria exposed to KCN (0.5 mM) in the presence
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of MgATP (1 mM) by measuring mitochondrial membrane poten-
tial in the absence or presence of JM-20 (5, 10 and 15 mM) or
oligomycin (1 mM). The conditions were the same as those
described for the mitochondrial membrane potential estimations.
2.14. Statistical analyses
The GraphPad Prism 5.0 (GraphPad Software Inc., USA) soft-
ware program was used for the statistical analyses. The data were
expressed as the means7S.E.M. Comparisons among groups were
performed using a one-way analysis of variance (ANOVA) followed
by the Newman–Keuls multiple comparisons test. Differences
were considered to be statistically signiﬁcant at Po0.05.
3. Results
3.1. Cytoprotective effects of JM-20 against glutamate-mediated
damage in PC-12 cells
PC-12 cell viability, as assessed using the MTT reduction assay,
was signiﬁcantly reduced (by approximately 45%) after exposure
to 50 mM glutamate for 24 h (Fig. 2). JM-20 treatment signiﬁcantly
prevented (Po0.05) cell death in a concentration-dependent
manner, with a very low half inhibitory concentration value
(IC50¼0.029 μM). Because the functionality of NMDA and GABA
receptors in PC-12 cells has not been clearly deﬁned (Hales and
Tyndale, 1994; Edwards et al., 2007), it was not possible to
evaluate the effect of the benzodiazepine fraction of JM-20 on
the activation of the ionotropic receptors by glutamate stimulation
in this cell line. We used a primary culture of cerebellar granule
neurons, which are affected by excitotoxic stimuli mediated by the
activation of the NMDA receptor via Ca2þ-mediated processes,
such as mitochondrial depolarization and ROS generation (Li et al.,
2004).
3.2. Cytoprotective effect of JM-20 against glutamate- or glutamate
plus pentylenetetrazole-mediated damage to primary cerebellar cell
cultures
Fig. 3A shows that exposure of primary cultures of cerebellar
granule neurons to 15 μM glutamate signiﬁcantly reduced cell
viability (by approximately 50%). JM-20 treatment increased cell
survival in a concentration-dependent manner, with a very
low IC50 value (0.011 mM). This molecule reached its maximal
protective effect at 0.1 mM, a concentration that is approximately
100 times lower than the concentrations of diazepam (DZP) and
nifedipine (Nif) that are required to see a similar effect. Fig. 3B
shows that the combined presence of glutamate (Glut) and
pentylenetetrazole (PTZ) in the incubation medium was more
cytotoxic than either compound individually, as expected. PTZ is
a well-known GABAA receptor antagonist (Pomés et al., 1993; Qu
et al., 2005) that inhibits regulatory GABAergic mechanisms in
cells. Under such conditions, JM-20 elicited a concentration-
dependent cytoprotective effect, with an IC50 value of 0.09 mM.
As expected, DZP was unable to confer substantial cytoprotection
to cells exposed to both neurotoxicants. Interestingly, nifedipine,
a well-known L-type Ca2þ channel blocker (Nguemo et al., 2013),
provided almost full protection to the cells at a concentration of
1 mM, which was similar to JM-20.
3.3. Cytoprotective effects of JM-20 against H2O2-induced oxidative
damage in PC-12 cell cultures
The effects of JM-20 against oxidative insults in PC-12 cell
cultures were investigated. Exposure of the cells to H2O2 for 18 h
signiﬁcantly reduced cell viability (by approximately 50%) com-
pared to undamaged control cells (Fig. 4). JM-20 exerted signiﬁ-
cant protective effects (Po0.05) against H2O2-induced cytotoxicity
at concentrations greater than or equal to 1 μM (Fig. 4). The
estimated IC50 value was 6.92 mM, a value that is substantially
higher than that observed when measuring the cytoprotective
effects of JM-20 against glutamatergic damage.
3.4. Protective effects of JM-20 against KCN-mediated damage
in PC-12 cell cultures
Incubation of PC-12 cells with KCN (800 mM) in glucose-free
medium for 1 h, followed by 24 h reperfusion (fresh growth
medium without KCN and with a high glucose content), resulted
in approximately 50% cell death. Fig. 5A shows a strong cytopro-
tective effect of JM-20 when it was added during hypoxia and the
reperfusion period (the lower cytoprotective concentration was
0.001 mM), with a very low IC50 value (0.008 mM). Fig. 5B also
shows a cytoprotective effect of JM-20 when it was added only
during the reperfusion state (the lower cytoprotective concentra-
tion was 0.01 mM). The estimated IC50 value under this condition
was 0.056 mM, a value that is seven times higher than that
obtained when JM-20 was incubated from the beginning of the
chemical-induced ischemic insult (0.008 mM). Given the fact that
the mitochondria play a critical role in ischemia/reperfusion-
induced neuronal cell injury (Sanderson et al., 2013), particularly
during glutamate- or oxidant-induced cell death (Pereira and
Oliveira, 2000; Hwang and Yen, 2008), we assessed the effects of
JM-20 in isolated rat liver mitochondria, which are a classical
model for studies of mitochondrial mechanisms (Zhu et al., 2002;
Zhang et al., 2008; Wang et al., 2009).
3.5. JM-20 protects the mitochondria from Ca2þ plus inorganic
phosphate (Pi)-mediated mitochondrial swelling and membrane
potential dissipation
A key pathogenic event during stroke is the opening of pores in
the inner mitochondrial membrane, the mitochondrial permeabil-
ity transition pores (mPTP) (Hirsch et al., 1998). In the next set of
experiments, we assessed the effects of JM-20 on Ca2þ and Pi-
induced opening of mPTP, as estimated by swelling of succinate-
energized rat liver mitochondria. This classic swelling technique
monitors the net inﬂux of the osmotic support associated with a
non-speciﬁc increase in membrane permeability. Fig. 6A shows
that 50 mM Ca2þ plus 2 mM Pi induced mitochondrial swelling, as
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Fig. 2. Protective effects of JM-20 against glutamate-induced excitotoxic damage in
PC-12 cells. The cells were seeded at a density of 1.5105 cells/ml in 96 multiwell
ﬂat bottom plates and were co-incubated with JM-20 (0.001–10 mM) and 50 mM
glutamate for 24 h. Cell viability was assessed using an MTT assay and expressed as
a percentage of the control. The data are presented as the means7S.E.M. of three
independent experiments. *Po0.05 versus Control; #Po0.05 versus JM-20 at
0 mM. The IC50 value was estimated using a non-linear regression algorithm.
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revealed by the large decrease in the turbidity of the mitochon-
drial suspension at 540 nm (trace a). This swelling was associated
with a faster mitochondrial membrane potential dissipation (Panel
B, trace a). JM-20 completely inhibited both swelling and mito-
chondrial membrane potential dissipation (trace e, and Panels A
and B, respectively) in a similar manner to the protection elicited
by the classic mPTP inhibitor, cyclosporine A (CsA, line f).
3.6. JM-20 prevented mitochondrial cytochrome c release in isolated
rat liver mitochondria
Cytochrome c release from the mitochondria plays an impor-
tant role in cell death (Li et al., 1997). Because we demonstrated
that JM-20 prevented neuronal cell death in different paradigms
associated with the ischemic process (Figs. 2–5), we next assessed
the potential involvement of inhibition of cytochrome c release;
Western blotting was used to detect the levels of free cytochrome
c in the supernatant fraction after mitochondrial swelling experi-
ments (Fig. 7). Ca2þ/Pi overload induced a substantial release of
cytochrome c from rat liver mitochondria, an effect that was
almost completely abolished by CsA and EGTA. JM-20 prevented
this release at low micromolar concentrations, in a concentration-
dependent manner.
3.7. JM-20 inhibits the hydrolytic activity of F1F0-ATP synthase
The hydrolytic activity of F1F0-ATP synthase is one of the largest
ATP consumers under ischemic conditions. This activity consumes any
available ATP and favors Ca2þ accumulation due to ATP-dependent
mitochondrial membrane potential recovery, potentiating mitochon-
drial damage (Christophe and Nicolas, 2006). Therefore, we evaluated
the effects of 5 μM JM-20 on the hydrolytic activity of F1F0-ATP
synthase for both the membrane-bound enzyme and its Triton
X-100 solubilized form (Fig. 8A). The inhibitory effects of JM-20 on
the enzyme activity (67%) followed a similar pattern to that of
oligomycin, a classical F1F0-ATP synthase inhibitor, showing a marked
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Fig. 3. Protective effects of JM-20 against glutamate-induced excitotoxic damage (A) or glutamate plus pentylenetetrazole (PTZ)-induced damage (B) in primary cultures of
cerebellar cells. The cells were seeded at a density of 5105 cells/ml in 96-multiwell ﬂat bottom plates. JM-20 (0.001–10 mM), nifedipine (Nif, 1, and 10 mM) and diazepam
(DZP, 1, and 10 mM) were co-incubated with 15 mM glutamate and/or 20 mM PTZ for 24 h. Cell viability was assessed using an MTT assay and expressed as a percentage of the
control. The data are presented as the means7S.E.M. of three independent experiments. *Po0.05 versus Control; #Po0.05 versus JM-20 at 0 mM. The IC50 value was
estimated using a non-linear regression algorithm.
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Fig. 4. Protective effects of JM-20 against H2O2-induced oxidative damage in PC-12
cells. The cells were seeded at a density of 1.5105 cells/ml in 96 multiwell ﬂat
bottom plates. JM-20 (0.1–10 μM) was co-incubated with 150 μM H2O2 for 18 h. Cell
viability was assessed using an MTT assay and expressed as a percentage of the
control. The data are presented as the means7S.E.M. of three independent
experiments. *Po0.05 versus Control; #Po0.05 versus JM-20 at 0 mM. The IC50
value was estimated using a non-linear regression algorithm.
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inhibition of the membrane-bound but not the solubilized form of the
enzyme. In intact mitochondria exposed to the cytochrome c oxidase
inhibitor, KCN, JM-20 also inhibited the hydrolytic activity of F1F0-ATP
synthase (Fig. 8B), as evidenced by its ability to prevent the ATP
hydrolysis-mediated recovery of the mitochondrial membrane poten-
tial after ATP addition.
3.8. JM-20 inhibits mitochondrial Ca2þ inﬂux
JM-20 inhibited Ca2þ inﬂux in succinate-energized rat liver
mitochondria (Fig. 9). JM-20 at a concentration of 15 mM elicited
64% inhibition (line c) in relation to the inhibition elicited by the
mitochondrial Ca2þ uniporter blocker, ruthenium red (line d).
4. Discussion
Neuroprotection for ischemic stroke refers to strategies applied
either individually or in combination that antagonize the injurious
biochemical and molecular events occurring in irreversible
ischemic injury (Ginsberg, 2008). The complexity of the ischemic
cascade, which is in contrast to the mono-ligand approaches
followed by the majority of investigations, has contributed to the
failures to improve clinical translation (Minnerup and Schäbitz,
2009). In this study, we demonstrated a strong cytoprotective
effect of JM-20, a new benzodiazepine-dihydropyridine hybrid
molecule, which was likely mediated through its multimodal
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Fig. 5. Protective effects of JM-20 against cyanide-induced chemical hypoxia in PC-
12 cells. The cells were seeded at a density of 1.5105 cells/ml in 96 multiwell ﬂat
bottom plates: (A) JM-20 (0.001–10 mM) was co-incubated with 800 mM KCN for 1 h
and maintained during the 24 h reperfusion period. (B) JM-20 (0.001–10 mM) was
added at the beginning of the 24 h reperfusion period. Cell viability was assessed
using an MTT assay and expressed as a percentage of the control. The data are
presented as the means7S.E.M. of three independent experiments. The X-axis in
Fig. 5A is the same as that in Fig. 5B. *Po0.05 versus Control; #Po0.05 versus JM-
20 at 0 mM. The IC50 value was estimated using a non-linear regression algorithm.
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Fig. 6. Protective effects of JM-20 against (A) Ca2þ plus Pi-mediated mitochondrial
swelling and (B) membrane potential dissipation. Rat liver mitochondria (RLM,
0.5 mg/ml) were incubated at 28 1C under continuous stirring in standard medium
that had been supplemented with 50 mM Ca2, as described in Section 2. For the
estimation of the mitochondrial membrane potential (Panel B), the medium also
contained 5 mM Safranine O. The experimental conditions were as follows: (a) no
JM-20 addition, (b) 2.5 mM JM-20, (c) 5 mM JM-20, (d) 10 mM JM-20, (e) 15 mM JM-
20, and (f) the condition outlined in (a) plus 1 mM cyclosporine A. RLM and CCCP
(1 mM) were added when indicated by the arrows. The results represent three
experiments that were conducted using different mitochondrial preparations.
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Fig. 7. Protective effects of JM-20 against cytochrome c release from the mitochon-
dria, as induced by Ca2þ and inorganic phosphate (Pi). Representative Western
blots and densitometric quantiﬁcation of free cytochrome c following the incuba-
tion of rat liver mitochondria under swelling conditions. Lane 1: 50 mM Ca2þ plus
2 mM Pi (Ca2þ/Pi). Lanes 2–6: Ca2þ/Pi plus 2.5, 5, 10, and 15 mM JM-20 as well as
1 mM Cyclosporine A plus 100 mM EGTA (CsA/EGTA), respectively. The data are
expressed as the means7S.E.M. of three independent experiments. *Po0.05
versus Ca2þ/Pi.
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action not only at the neural level but also at the mitochondrial
level. We used two cellular models of exposure to either glutamate
or H2O2, which have been associated with neuronal injury during
ischemia. In such cell death paradigms, JM-20 was able to protect
cells at very low micromolar concentrations, with IC50 values of
0.029, 0.011, 0.09, 0.008 and 0.056 mM for PC-12 cells exposed to
glutamate, cerebellar cells exposed to glutamate or to glutamate
plus PTZ, and PC-12 cells exposed to KCN during chemical-induced
hypoxia or reperfusion, respectively.
Excitotoxicity is one of the main mechanisms underlying
neuronal death during stroke, which is triggered by a massive
extracellular release of the excitatory transmitter glutamate, lead-
ing to intracellular Ca2þ overload, mitochondrial dysfunction, and
eventually cell death (Dirnagl et al., 1999). In addition, the
generation of ROS, such as hydroxyl radicals, superoxide anions
and nitric oxide, can cause lipid peroxidation and membrane
damage (Love, 1999; Warner et al., 2004), and may eventually
lead to neuronal apoptosis or necrosis, depending on the intensity
of the initial insult and the extent of energy recovery (Sims and
Muyderman, 2010). Given the chemical structure of JM-20, its
anti-excitotoxic effects may be due to its ability to counteract the
excitatory glutamate response by stimulating inhibitory GABA
reactions (benzodiazepine moiety) and/or to act as an inhibitor
of glutamate-mediated Ca2þ entry in the neurons (dihydropyr-
idine portion). We recently demonstrated GABAergic effects of JM-
20 in different relevant animal models (Figueredo et al., 2014);
therefore, we presumed that this mechanism may contribute, at
least in part, to the anti-glutamatergic and neuroprotective effects
elicited by JM-20 in cells. The anti-Ca2þ effect was indirectly
demonstrated in the experiment in which cerebellar granule cells
were exposed to PTZ plus glutamate. PTZ is a chemical convulsant
frequently used in the study of seizures. It is generally accepted
that PTZ exerts its effects by binding to the picrotoxin-binding site
of the postsynaptic GABAA receptor. PTZ reduces GABA-mediated
responses in a concentration-dependent manner (Eloqayli et al.,
2002). Cells treated with PTZ plus glutamate showed a lower
percentage of survival than those exposed to each cytotoxic
compound individually. One of the mechanisms implicated in
the neuroprotective effects of GABAergic transmission is inactiva-
tion of the excitatory glutamate receptors (Herrero et al., 1999;
Green et al., 2000; Ouyang et al., 2007). Thus, the increase in cell
death after cell exposure to glutamate plus PTZ may be due to the
blockade of the endogenous GABAergic response by PTZ, which
may leave cells more susceptible to the toxicity of NMDA receptor-
mediated Ca2þ overload. In this context, JM-20 maintained its
neuroprotective properties and protected cerebellar granule neu-
rons with a very low IC50 value, suggesting that JM-20 has a
neuroprotective effect that is mediated by mechanisms that are
not simply associated with the GABAergic response. Indeed, the
lack of DZP effect and the strong nifedipine protection that took
place under this experimental condition suggest that JM-20 may
be acting as a Ca2þ antagonist or that JM-20 may be more potent
than DZP in acting on GABA receptors. Because we recently
observed that DZP was almost twice as potent as JM-20 when
acting as an anxiolytic in vivo (Nuñez-Figueredo et al., 2014), the
former mechanistic assumption most likely contributes more to
the neuroprotection elicited by JM-20 under the conditions out-
lined above. Moreover, when cells were injured only with gluta-
mate, JM-20 reached its maximal neuroprotective effect at 0.1 mM
(IC50 value¼0.011 mM), a concentration that was 100 times lower
than that by which nifedipine or DZP elicited full cell protection
(10 mM). These results suggest that the strong neuroprotective
action of JM-20 may involve both anti-excitotoxic and anti-Ca2þ
effects, rendering JM-20 a potential neuroprotective agent. Accord-
ingly, due to the importance of Ca2þ overload for cell death, dual
Ca2þ channel and NMDA receptor modulators are considered to be
useful neuroprotective drugs in neurodegenerative diseases (Van
der Schyf, 2011).
Oxidative stress is another key mediator of the ischemic
process, particularly after reperfusion (Endres et al., 2008). In this
sense, it is not surprising that several antioxidants are under pre-
clinical or clinical investigation as neuroprotective agents during
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Fig. 8. Inhibition of the hydrolytic activity of F1F0-ATP synthase by JM-20, as
assessed in (A) submitochondrial particles and (B) isolated rat liver mitochondria.
The experimental procedures are described in Section 2. Submitochondrial parti-
cles (20 mg of protein) were incubated in the absence or presence of JM-20 (5 mM),
oligomycin (1 mM), or 0.1% (v/v) Triton X-100. Isolated mitochondria (0.5 mg/ml)
were incubated in standard medium that had been supplemented with 5 mM
Safranine O in the absence (trace a) or presence of 5, 10 and 15 mM JM-20 (traces b,
c, and d, respectively). Oligomycin at a concentration of 1 mM was used as a control
for enzyme inhibition (trace e). RLM, KCN, MgATP and CCCP (1 mM) were added
when indicated by the arrows. The results represent three experiments that were
conducted using different mitochondrial preparations. *Po0.05 versus Control
with no triton.
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Fig. 9. Protective effects of JM-20 against Ca2þ inﬂux in the mitochondria. Rat liver
mitochondria (RLM, 0.5 mg/ml) were incubated in a standard incubation medium,
as described in Section 2, and supplemented with 150 nM Calcium Green 5 N in the
absence (trace a) or presence of 5 and 15 mM JM-20 (traces b and c, respectively) or
Ruthenium Red (1 mM), the classical Ca2þ uniporter channel blocker (trace d). RLM,
Ca2þ (20 mM) and CCCP (1 mM) were added when indicated by the arrows. The
traces represent three experiments that were conducted using different mitochon-
drial preparations.
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ischemic stroke (Lau and Tymianski, 2010). JM-20 prevented H2O2-
induced PC-12 cell death at relatively high concentrations that
were one hundred times higher than those required for JM-20-
mediated neuroprotection against glutamate or KCN-induced cell
damage, suggesting that the antioxidant mechanism is indirectly
involved in the neuroprotective action of JM-20. In fact, although
very low, the IC50 value for PC-12 cell protection against glucose
and chemical-induced anoxia was seven times higher when JM-20
was added during the reperfusion stage than when it was added
from the beginning of the experiment. Because mitochondrial ROS
generation seems to be secondary to Ca2þ inﬂux via NMDA
receptors (Lau and Tymianski, 2010) and because mitochondrial
Ca2þ accumulation seems to play a key role in glutamate excito-
toxicity (Nicholls et al., 2003), the neuroprotection elicited by
JM-20 against oxidant-induced cell damage or during ischemia/
reperfusion suggests that it could be acting either upstream of the
mitochondria or at the organelle level. In this regard, mitoprotec-
tion could be another important mechanism contributing to the
overall neuroprotective action of JM-20 because diazepam and
nimodipine, both of which exhibit structural similarities to JM-20,
have been reported to protect neuronal cells in different experi-
mental models of brain ischemia via mitochondrial mechanisms
(Taya et al., 2000; Sarnowska et al., 2009). Therefore, in the
present study, we also addressed the idea that the mitochondria
are potential pharmacological targets for the neuroprotective
action of JM-20.
Under normal conditions, the mitochondria are primarily active
during energy metabolism and as high-capacity Ca2þ sinks
(Giacomello et al., 2007). However, the excessive mitochondrial
Ca2þ loading following an ischemic insult may result in the
opening of mitochondrial permeability transition pores (mPTP)
(Sullivan et al., 2005). This mPTP opening will in turn result in a
massive leak of protons and complete and immediate dissipation
of the mitochondrial membrane potential, indicating a commit-
ment to death. The release of cytochrome c from the inter-
membrane space of the mitochondria to the cytosol is one of the
critical events that occurs during apoptotic neuronal cell death
(Lau and Tymianski, 2010; Fiskum, 2000). In some cases of
apoptosis, mPTP opening is involved (Kroemer, 1997). Thus, mPTP
has been proposed to be integral to the apoptotic mechanism
implicated in ischemia-triggered mitochondrial dysfunction and
neuronal cell death (Mazzeo et al., 2009). Accordingly, agents that
can block mPTP opening have produced neuroprotective effects, as
demonstrated in several studies (Osman et al., 2011; Zhu et al.,
2002; Zhang et al., 2008; Wang et al., 2009). In the present study,
we demonstrated the protective effect of JM-20 against Ca2þ-
induced mPTP opening and mitochondrial membrane potential
dissipation, together with the inhibition of Ca2þ-induced cyto-
chrome c release from mitochondria. These effects may be asso-
ciated with the ability of JM-20 to prevent neuronal cell death
induced by glutamate or H2O2, which are well known inducers of
cytochrome c-mediated neuronal cell death (Pereira and Oliveira,
2000; Hwang and Yen, 2008).
JM-20 signiﬁcantly prevented mitochondrial Ca2þ inﬂux,
which may have been responsible for the Ca2þ-induced mito-
chondrial swelling. In this regard, abnormal Ca2þ accumulation by
neuronal mitochondria in response to excitotoxic levels of excita-
tory neurotransmitters, such as glutamate, is an important med-
iator of mitochondrial dysfunction and delayed cell death (Fiskum,
2000; Drago et al., 2011). Thus, JM-20-mediated protection against
Ca2þ-induced mitochondrial impairment and its neuroprotective
effects may include its ability to prevent mitochondrial Ca2þ
inﬂux.
JM-20 does more than just prevent Ca2þ-mediated mitochon-
drial damage. It also inhibits the hydrolytic activity of F1F0-ATP
synthase in both submitochondrial particles and intact mitochondria
at low micromolar concentrations, suggesting that JM-20 crosses
the mitochondrial membrane and targets the enzyme, thus pre-
serving the existing ATP during ischemia and promoting neuronal
cell survival. F1F0-ATP synthase is responsible for mitochondrial
ATP synthesis in mammalian cells. However, it can also hydrolyze
ATP during cellular anoxia, so the direction of the reaction has a
profound effect on cellular metabolism (Jennings et al., 1990).
During anoxia, the electrochemical gradient collapses and F1F0-
ATP synthase switches to its hydrolytic state, causing undesirable
ATP hydrolysis, leading to ATP depletion (Grover et al., 2008).
Thus, preserving ATP through the inhibition of F1F0-ATP synthase
hydrolytic activity may represent a protective strategy for neuro-
nal cells exposed to ischemic damage (Christophe and Nicolas,
2006). Therefore, our results suggest that JM-20 may also prevent
neuronal cell death during ischemia by maintaining the cellular
energy balance, which in turn may drive neuronal recovery
processes.
5. Conclusion
The results of the present study support a pleiotropic mechan-
ism underlying the neuroprotective action of JM-20, which may
involve both anti-excitotoxic and anti-Ca2þ effects at the neuronal
level as well as mitoprotective effects against Ca2þ-induced
impairment in association with ATP preservation. The neuropro-
tective activity of JM-20 in vitro, as evidenced in this study,
prompted us to extend our research to in vivo experimental
models of brain damage, which are now underway.
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